Molecular mechanisms and targeted interventions for embolic risk in cardiac myxoma: from molecular heterogeneity to clinical translation - Quiz - MDSpire

Molecular mechanisms and targeted interventions for embolic risk in cardiac myxoma: from molecular heterogeneity to clinical translation

  • By

  • Shichao Guo

  • Zhiyuan Wang

  • Yingying Guo

  • Youwei Zhao

  • July 7, 2026

  • 0 min

Share

Original Source(s)

Molecular mechanisms and targeted interventions for embolic risk in cardiac myxoma: from molecular heterogeneity to clinical translation

  • by Shichao Guo, Zhiyuan Wang, Yingying Guo, Youwei Zhao

  • July 7, 2026

Related Content

Integrative radiomics and habitat imaging models for predicting PD-L1 expression in non-small cell lung cancer

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report

Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort